市場調查報告書
商品編碼
1210897
全球宏基因組學市場規模研究與預測:按技術、產品、應用、工作流程和地區分析,2022-2029 年Global Metagenomics Market Size study & Forecast, by Technology by Product, by Application, by Workflow and Regional Analysis, 2022-2029 |
2021 年全球宏基因組市場價值約為 14.6 億美元,預計在 2022-2029 年預測期內將以超過 14.0% 的健康增長率增長。
宏基因組學使用全基因組測序來研究自然環境中所有微生物群成員的完整基因組成。 宏基因組分析是一個專注於對從人類消化道(腸道菌群)和地熱溫泉等各種棲息地分離的微生物基因組進行直接遺傳分析的領域。 由於測序成本下降、生物技術和生物信息學技術的進步以及對用於各種研究的微生物篩選的興趣增加等因素,宏基因組學市場正在擴大。
這是由於技術突破、研發支出增加、測序成本下降以及宏基因組學知識的增加。 此外,對生物信息學的投資以支持宏基因組學和微生物組分析,以及研究人員對宏轉錄組學、代謝組學和宏蛋白質組學領域的興趣日益濃厚,這些發展是推動市場擴張的其他因素。是的一部分 例如,SeqOne 在 2022 年 1 月籌集了 2000 萬歐元的 A 輪融資。 對開發下一代基因組學和生物信息學的公司的投資越來越多。 此外,人們對病毒性腹瀉、流感、乙型肝炎和 HIV/AIDS 等病毒性疾病的興趣日益濃厚,以及被發現的基因數量不斷增加,這些都催生了新的宏基因組研究產品。 聯合國艾滋病署估計,到 2022 年全球將有 3770 萬艾滋病病毒感染者。 自疫情開始以來,已有7930萬人感染了艾滋病毒。 新感染艾滋病毒的人數下降了 52%。 大約有 150 萬人新感染了艾滋病毒。 因此,病毒性疾病流行率的上升正在為市場創造有利可圖的增長。 然而,宏基因組學的高成本將阻礙整個 2022-2029 年預測期內的市場增長。
全球宏基因組學市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 在這些地區中,由於老年人口增加、慢性病預防率上升以及該地區主要市場參與者數量增加等因素,北美所佔份額最大。 此外,由於目標人口增加和該地區研發活動增加等因素,預計亞太地區將出現顯著增長。
這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和技術產品的深入分析。
Global Metagenomics Market is valued approximately USD 1.46 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2022-2029. Metagenomics is the study of the full genetic makeup of every microbiota member in a natural environment using the whole genome sequencing method. Metagenomics is a field that focuses on the direct genetic analysis of microbial genomes that have been isolated from a variety of habitats, including the human gastrointestinal tract (gut microbiome) and geothermal hot springs. The Metagenomics market is expanding because of factors such as rising declining expenses of sequencing, developments in biotechnology & bioinformatics techniques and rising interest in microbial screening for different investigations.
Technological breakthroughs, rising research and development spending, falling sequencing costs, and increased knowledge of metagenomics are all credited. In addition, investments in bioinformatics to support metagenomics and microbiome profiling as well as researchers' increased interest in the fields of meta transcriptomics, metabolomics, and metaproteomics as well as these developments are some other drivers boosting the market's expansion. As an example, SeqOne raised EUR 20 million in a Series A round in January 2022. Growing investments are now being made in firms that are developing the next generation of genomics and bioinformatics. Furthermore, New metagenome study products have been created as a result of growing worries about viral diseases such virus-induced diarrhoea, influenza, hepatitis B, and HIV/AIDS as well as an increase in the number of genes being discovered. United Nations AIDS estimates that 37.7 million individuals worldwide with HIV as of 2022. Since, the onset of the epidemic, 79.3 million people have contracted HIV. The number of new HIV infections has fallen by 52%. And there were almost 1.5 million new HIV infections. Thus, rising prevelance of viral diseases is creating a lucrative growth to the market. However, the high cost of Metagenomics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Metagenomics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Among these region, North America holds the largest share owing to factors such as rising geraiticgeriatric population, rising prevelanceprevalence of chronic disease and rising number of key market players in the region. Furthermore, Asia Pacific region is expected to grow at a significant rate owing to factors such as rising target population, and rising research and development activities in the region.
Major market players included in this report are:
Bio-Rad Laboratories
Illumina, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Novogene Co., Ltd.
Promega Corporation
QIAGEN
Takara Bio, Inc.
Oxford Nanopore Technologies
F. Hoffmann-La Roche Ltd.
Recent Developments in the Market:
Global Metagenomics Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Technology, Product, Application, Workflow, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Shotgun Sequencing
16S Sequencing
Whole Genome Sequencing
Others
By Product:
Kits and Reagents
Sequencing & Data Analytics Services
Software
Application:
Environmental Application
Clinical Diagnostics Applications
Drug Discovery Applications
Biotechnology Applications
Food & Nutrition Applications
Other Application
By Workflow:
Pre-sequencing
Sequencing and Data Analysis
Product:
Human Metagenomics
Metagenomics Analog
By Distribution Channel:
Hospitals
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable